15. 封入体筋炎
[臨床試験数:39,薬物数:32(DrugBank:11),標的遺伝子数:11,標的パスウェイ数:119

Searched query = "Inclusion body myositis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02483845
(ClinicalTrials.gov)
May 201331/5/2013Natalizumab in Inclusion Body Myositis (IBM)Pilot Study of Natalizumab in the Treatment of Patients With Inclusion Body MyositisInclusion Body Myositis (IBM)Drug: NatalizumabPhoenix Neurological Associates, LTDNULLActive, not recruiting21 Years85 YearsAll6Phase 1United States